CJC1295 with DAC

CJC-1295 with DAC research reference

CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). The Drug Affinity Complex (DAC) modification is designed to extend exposure, and published human research has examined sustained effects on growth hormone and IGF-1 signaling.

Research areas

• GHRH receptor signaling.
• Growth hormone and IGF-1 dynamics.
• Pharmacokinetic behavior of long-acting GHRH analogues.

Evidence context

Clinical studies are limited and do not establish a general therapeutic indication for this listing.

For research purposes only. Not intended for human consumption, self-administration or use as a medicine.